Bryan Angle, MD
Retina Specialist · Corpus Christi, TXNPI 1457323537
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,622 of the $1,832 with a category attached, or 88.5%. 14 manufacturers reported payments, led by Alcon at 36.4% of the total. Reporting peaked in 2024 at $726 and has fallen 63.2% since, to $267 in 2025. That places this record below the midpoint for retina specialist clinicians in TX, where the typical reported total is $2,568.
Across 40 payments — averaging $45.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$667
- Regeneron Healthcare Solutions, Inc.$251
- Genentech USA, Inc.$230
- Carl Zeiss Meditec, Inc.$161
- Novartis$143
- Alimera Sciences, Inc.$118
- plus $262 from 8 others
Across 8 payments — averaging $16,825 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Genentech, Inc.$135K
What the payments were for
- Travel & lodging$19311%
- Food & beverage$1,62289%
- Gifts$171%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 5 | $667 |
| Regeneron Healthcare Solutions, Inc. | 9 | $251 |
| Genentech USA, Inc. | 6 | $230 |
| Carl Zeiss Meditec, Inc. | 2 | $161 |
| Novartis | 5 | $143 |
| Alimera Sciences, Inc. | 5 | $118 |
| Harrow Eye, LLC | 1 | $89 |
| Biotissue Holdings Inc. | 1 | $38 |
| Astellas Pharma US Inc | 1 | $32 |
| Biogen | 1 | $26 |
| Apellis Pharmaceuticals, Inc. | 1 | $22 |
| ANI Pharmaceuticals, Inc. | 1 | $21 |
| Spark Therapeutics, Inc. | 1 | $20 |
| Mallinckrodt Hospital Products Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,832 in reported general payments places this provider in the 40th percentile of 108 retina specialist providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 11 | $243 |
| Latanoprost | 11 | $51 |
Paid to pharmacies, not to this prescriber.
Other retina specialist in Corpus Christi
- Rashed AlhabshanCorpus Christi$3K
- Charles CampbellCorpus Christi$2K
- Courtney CrawfordBurleson$342K
- Jeremiah BrownSchertz$339K
- Victor GonzalezMcAllen$335K
- Judy KimDallas$256K
- Emmanuel ChangBellaire$254K
- Ting Fang SuarezBellaire$156K
- Hemang PandyaPlano$153K
- Margaret RunnerSouthlake$71K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.